Nov. 27 is Here: What Does That Mean for DSCSA?

A session investigates the drivers of these shortages and ways to mitigate them.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

A case study explores a way to potentially transform commercial organizations, while driving revenue growth.

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

The value of this sometimes-unheralded technology to the pharma industry—as well as potential use cases—are starting to come to light.

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.